ATNMNYSE United States
Market cap
$25.018 M
$0.80 +1.32%
Close of 7 Aug 2026
Revenue
$90.0K
#3614 by revenue
Earnings
-$33.9M
Loss-making
Shares outstanding
31,441,436
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Where these numbers come from
Share counts and financials for Actinium Pharmaceuticals are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.